NCT05238831 2024-01-23SMMART Adaptive Clinical Treatment (ACT) TrialOHSU Knight Cancer InstitutePhase EARLY_PHASE1 Withdrawn
NCT05174455 2023-09-18Niraparib for the Treatment of LeiomyosarcomaOhio State University Comprehensive Cancer CenterPhase 2 Withdrawn